baber/WOPTO huggingface dataset:
Patent AT-E174967-T1 (AT)
Inventor: CIANFRIGLIA MAURIZIO
IPC: G01N33/53
Filed: 1993-06-16
Granted: 1999-01-15
Abstract: PCT No. PCT/EP93/01533 Sec. 371 Date Dec. 15, 1994 Sec. 102(e) Date Dec. 15, 1994 PCT Filed Jun. 16, 1993 PCT Pub. No. WO93/25700 PCT Pub. Date Dec. 23, 1993A monoclonal antibody that recognises a structurally continuous and extracellularly-located epitope of human P-glycoprotein is described. The monoclonal antibody has a continuous amino acid sequence, and a binding affinity for the P-glycoprotein which manifests in the ability to stain greater than 90% of live CEM-VBL10 cells in a flow cytometry assay.
Patent AT-E158484-T1 (AT)
Inventor: LINGWOOD ANTHONY MICHAEL
IPC: A47J37/07
Filed: 1993-05-28
Granted: 1997-10-15
Abstract: PCT No. PCT/GB93/01136 Sec. 371 Date Feb. 3, 1995 Sec. 102(e) Date Feb. 3, 1995 PCT Filed May 28, 1993 PCT Pub. No. WO94/03093 PCT Pub. Date Feb. 17, 1994An outdoor device cooks food and includes a heat source. A support supports the food to be cooked above the heat source. A baffle is interposed between the heat source and the food support. The baffle is located and shaped so as to both prevent drippings from the food being cooked from falling onto the heat source and collect the drippings together above the heat source. A receptacle is disposed below the heat source and the drippings are channeled from the baffle to the receptacle without contacting the heat source.
Patent AT-E222725-T1 (AT)
Inventor: HOCHMAN DARYL
IPC: A61B10/00
Filed: 1993-06-07
Granted: 2002-09-15
Abstract: The present invention provides a method for imaging margins, grade and dimensions of solid tumor tissue located in an area of interest, comprising illuminating the area of interest with high intensity, emr (electromagnetic radiation) containing the wavelength of emr absorbed by a dye, obtaining a video signal of the area of interest as an averaged control image and processing the averaged control image into the averaged control frame, administering the dye by bolus injection into a vein circulating to the area of interest, obtaining a series of video images of the area of interest over time as subsequent images and processing each subsequent image as a subsequent frame, comparing each subsequent frame with the processed averaged control frame to obtain a series of difference images, and comparing each difference image for initial evidence of changed absorption within the area of interest which is the outline of solid tumor tissue, whereby tumor tissue is characterized by faster absorption of emr as a result of increased vascularity of solid tumor tissue and inability to clear the dye as fast as normal tissue.
Patent AT-E153663-T1 (AT)
Inventor: BOETTCHER HENNING DR
IPC: A61K31/443
Filed: 1994-09-20
Granted: 1997-06-15
Abstract: Piperidine and piperazine derivatives of the formula I <IMAGE>  wherein   Ind is an unsubstituted indol-3-yl radical or one which is mono- or disubstituted by OH, OA, CN, Hal, COR<2> or CH2R<2>, R' is benzofuran-5-yl or 2,3-dihydrobenzofuran-5-yl, chroman-6-yl, chroman-4-on-6-yl, 3-chromen-6-yl or chromen-4-on-6-yl which are unsubstituted or monosubstituted by CN, CH2OH, CH2OA or COR<2>,   Q is CmH2m,   Z is N or CR<3>,   A is alkyl having 1-6 C atoms,   Hal is F, Cl, Br or I,   R<2> is OH, OA, NH2, NHA or NA2,   R<3> is H, OH or OA and   m is 2, 3 or 4, and their physiologically acceptable salts affect the central nervous system.
Patent AT-E173447-T1 (AT)
Inventor: CLAUT DEMETRIO
IPC: B65H63/06
Filed: 1994-05-21
Granted: 1998-12-15
Abstract: An improved method and device for winding yarn into bobbins, in which the yarn is cut on command such as to make its cut end wind onto the central portion of the surface of the bobbin under formation, in order to facilitate restoration of yarn continuity and restart of winding. <IMAGE>
Patent AT-E163412-T1 (AT)
Inventor: DOLLE ROLAND E
IPC: A61K31/50
Filed: 1994-06-04
Granted: 1998-03-15
Abstract: Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: <CHEM>  wherein R1 is halogen, oxygen linked leaving group including aromatic ether, aromatic ester, alkyl sulfonate, aryl sulfonate, alkyl phosphonate, aryl phosphonate, alkyl phosphate or aryl phosphate; R2 is OR5, NH(CHR5)m-COOR5, NH(CHR5)mCON(R5)R6, N(R5)R6 or NH(CHR5)nOH;     R3 is H or alkyl;     R4 is H, substituted or unsubstituted aryl, heteroaryl or alkyl; R5 and R6 are independently H, lower alkyl, aryl, heteroaryl, aralkyl, heteroaralkyl or lower cycloalkyl;     m = 1-6; and     n = 2-6. pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1 beta  protease activity in a mammal utilizing the compounds and compositions.
Patent AT-E183638-T1 (AT)
Inventor: NAPOLITANO NEIL J
IPC: A23G4/00
Filed: 1994-03-02
Granted: 1999-09-15
Abstract: A solid dosage form for relieving xerostomia symptoms comprises a lubricating polymer comprising polyethylene oxide and a sialogogue in a pharmaceutically acceptable, substantially non-cariogenic, carrier.
Patent AT-E175413-T1 (AT)
Inventor: ELLINGBOE JOHN WATSON
IPC: A61K31/505
Filed: 1994-03-16
Granted: 1999-01-15
Abstract: This invention relates to intermediates useful in the production of substituted pyridopyrimidinones of general formula (I): <CHEM>  wherein     n is 0 to 3; R<1> and R<2> are, independently, H, C1-C6alkyl, hydroxy(C1-C6alkyl), formyl, carbonyl(C1-C6alkyl), carboxy, or carboxy(C1-C6alkyl);   R<3> and R<4> are, independently, H, C1-C6alkyl, or hydroxy; R<3a> and R<4a> are H, or one of -CR<3>R<3a> and -CR<4>R<4a> is a carbonyl group; with the proviso that at least one of the groups R<1> and R<2> must be hydroxy(C1-C6alkyl), formyl, carbonyl(C1-C6alkyl), carboxy, or carboxy(C1-C6alkyl); or one of R<3> and R<4> must be hydroxy; or one of -CR<3>R<3a> and -CR<4>R<4a> must be a carbonyl group; ;   Ar<1> is <CHEM>     wherein W is H, C1-C6alkyl, halogen, hydroxy, or C1-C6alkoxy;   Ar<2> is <CHEM>     wherein X is <CHEM> wherein R<5> is H, CH3, tert-butyl, tri-n-butylstannyl, or triphenylmethyl; or a tautomer of said compound,  or a pharmaceutically acceptable salt of said compound or tautomer. The compounds of Formula I are useful for treating hypertension and congestive heart failure. Also disclosed are pharmaceutical compositions containing compounds of Formula I and a pharmaceutically acceptable carrier and methods for production of the compounds of Formula I. Intermediates for making the pharmaceutical useful compounds are also enclosed.
Patent AT-E181044-T1 (AT)
Inventor: WEBER OSCAR W
IPC: C02F1/52
Filed: 1994-03-31
Granted: 1999-06-15
Abstract: A highly colored dye wastewater is treated by a sequence of steps to obtain a color reduction of 90 percent or more. The method requires acidifying the wastewater and adding a cationic flocculant. A reducing agent is then, optionally, added to further reduce the color value of the wastewater and produce an oxidation-reduction potential of at least -200 and, generally, about -400 to -800. The reducing agent is, preferably, either a hydrosulfite or both a bisulfite and an alkali metal borohydride.
Patent AT-E152523-T1 (AT)
Inventor: STEFAS ELIE
IPC: C12N7/02
Filed: 1994-02-09
Granted: 1997-05-15
Abstract: PCT No. PCT/FR94/00142 Sec. 371 Date Aug. 10, 1995 Sec. 102(e) Date Aug. 10, 1995 PCT Filed Feb. 9, 1994 PCT Pub. No. WO94/18569 PCT Pub. Date Aug. 18, 1994A method for detecting and/or assaying viral compounds, wherein the viral compounds are bound with  beta 2'-glycoprotein I which is a glycoprotein having a molecular weight of 50,000+/-3,000 daltons from the method for producing albumin obtained as a blood plasma by-product according to FR-A 2 690 444. Viral compound separation may be simplified by binding the  beta 2'-glycoprotein I to a preferably solid support or by binding the viral compounds to a support and exposing same with the  beta 2'-glycoprotein I conjugated with a marker. A solid support to which at least the  beta 2'-glycoprotein I is bound, is also disclosed.
Patent AT-E171934-T1 (AT)
Inventor: HARLING JOHN DAVID
IPC: C07D333/28
Filed: 1994-07-21
Granted: 1998-10-15
Abstract: Compounds of formula (I) and salts thereof are useful for treating accumulation of calcium in brain cells, wherein X represents O, S, NH or a bond; p and q independently represent 0-4 such that the sum of p + q is at least 1; R<1> and R<2> each independently represent hydrogen, C1-6alkyl, C3-6cycloalkyl, or C1-4alkyl-C3-6cycloalkyl; n is 1, 2 or 3; and Ar represents phenyl optionally substituted by 1 to 3 substituents selected from: halo, C1-4alkyl, C1-4alkoxy, C1-2alkylenedioxy, trifluoromethyl, trifluoromethoxy, CN, NO2, amino, mono- or di-alkylamino, optionally substituted benzoyl and Ph(CH2)rY(CH2)s- where Ph is optionally substituted phenyl, Y is oxygen or a bond and r and s each independently represent 0-4 provided that the sum of r + s is not greater than 4, or Ar represents an optionally substituted unsaturated monocyclic heteroaryl ring system containing 5 or 6 ring members, or an optionally substituted, unsaturated or partially saturated bicyclic aryl or heteroaryl ring system containing 8-10 ring members.
Patent AT-E151521-T1 (AT)
Inventor: STANNEK SIEGFRIED
IPC: F28D1/053
Filed: 1994-07-22
Granted: 1997-04-15
Abstract: A heating body, in particular a tubular heating body, is disclosed, as well as a process and device for producing in particular such a heating body. The heating body is provided with adapters (56) arranged in a row forming an upper and a lower collecting pipe and provided each with at least one opening. At least one heating tube (52) is arranged between every two adapters and is connected thereto. The adapters (56) have each at least one collecting pipe branch (66) provided with individual openings (58) at its circumference. The collecting pipe branch (66) is surrounded by a housing part (57), except for a projecting section, and the housing part (57) has openings for the heating tube(s).
Patent AT-E166499-T1 (AT)
Inventor: SCHULTE REINHOLD
IPC: H02J13/00
Filed: 1994-09-22
Granted: 1998-06-15
Abstract: In order to improve the auxiliary operation of ripple-control equipment (4, E) in the event of a breakdown of the transmission of information to the ripple-control equipment (4, E), incoming ripple-control signals are continuously detected and statistically evaluated, and the performance of the information transmission is monitored. When information transmission breaks down, auxiliary control signals to switch on or off at least one consumer are automatically generated on the basis of the statistically evaluated ripple-control signals.
Patent AT-E188601-T1 (AT)
Inventor: DRUAIS HERVE
IPC: A61B19/00
Filed: 1994-09-06
Granted: 2000-01-15
Abstract: PCT No. PCT/FR94/01050 Sec. 371 Date Sep. 10, 1996 Sec. 102(e) Date Sep. 10, 1996 PCT Filed Sep. 6, 1994 PCT Pub. No. WO95/07055 PCT Pub. Date Mar. 16, 1995Computer-assisted microsurgery equipment, of the type including an articulated tool support, with one of the ends being integral with a fixed reference system Rc. The system comprises cameras for determining the tool coordinates in said fixed reference system Rc, and an image data base wherein are recorded images from an imaging system in the image reference system Ri. The inventions characterized by having at least two sensors integral with the fixed reference system Rc supplying an electrical signal depending on the patient reference position Rp in the fixed reference system Rc, and a computer for matching the tool reference system Ro with the patient reference system Rp and the image reference system Ri according to data from the bidimensional sensor, cameras for determining the coordinates of the tool in the fixed reference system Rc and data from the image base. The computer supplies a signal for displaying the position of the tool in the image reference system Ri on a monitor and for controlling the position and shifting of said tool as a function of the control signals from the control unit.
Patent AT-E165594-T1 (AT)
Inventor: MATTHEWS DONALD P
IPC: C07D295/08
Filed: 1994-08-19
Granted: 1998-05-15
Abstract: The present invention relates to novel triaryl-ethylene derivatives that are useful as anti-neoplastic agents, antiatherosclerotic agents, and hypocholesterolemic agents.
Patent AT-E193201-T1 (AT)
Inventor: SCHMITZ CHRISTOPH JOHANN
IPC: A61F13/49
Filed: 1995-02-16
Granted: 2000-06-15
Abstract: In an absorbent article, a mechanical fastening system is provided wherein the landing member (64) comprises a loop-type material. The landing member is elastically extensible in the direction of the front transverse edge by at least 5 %, preferably at least 30 %, so that it allows for elastic contraction and expansion of the front waist region. The landing member (64) may be of extensible material and may be formed by the topsheet material which projects beyond the front transverse edge of the backsheet, or topsheet material which is doubled over at the front waist region. Alternatively, the backsheet comprises a front waist section of different material than the back waist section. A separate elastic element may be associated with the landing member, or the landing member itself may be of stretchable loop-type material. In another embodiment, the landing member comprises at least one cut-out section (90) in the backsheet through with the loop-type material of the landing member is exposed.
Patent AT-E167925-T1 (AT)
IPC: F16L3/04
Filed: 1995-03-01
Granted: 1998-07-15
Abstract: The device has a U-shaped fixing bar (1) having two arms (3,4) connected to a base area (2) and a fastening bracket (6) at the end of one arm which can be placed against the ground. At least the base area is covered on its surface remote from the pipe holding area (5) with a soft resilient insulating material (8) such as foam or foam-fleece compound. The insulating material can extend at least over part of the outside faces of the arms facing the base. The arms and the straight base are at right angles to each other. The base area can be connected directly to the ground by a screw connection. The length of the arms can be shorter than the vertical dimensions of the pipe being held. The two arms can have the same or different length.
Patent AT-E204532-T1 (AT)
Inventor: YANAGISAWA TATEO
IPC: B29C31/00
Filed: 1991-04-11
Granted: 2001-09-15
Abstract: A bottle comprising a main body and a handle body (2) having engaging protusions (26,27) wrapped up by the main body for integrating the handle body (2) with the main body.
Patent AT-E181284-T1 (AT)
Inventor: BAYER HARALD
IPC: B41F21/04
Filed: 1995-08-11
Granted: 1999-07-15
Abstract: The drum has grip bridges each comprising a shaft with grips and an adjustable stop bar. These are evenly spaced round the drum periphery. The bars (18) are separately adjustable for height and depth, there being a drive mechanism (5) housed inside the drum trunnion (4) and fixed to the press frame (1). The drive mechanism engages in succession via a coupling mechanism (12) with adjusting components (15) actuated in succession. These are in turn coupled to positioning mechanism (16,17) for the individual bars. The drive can consist of a controllable electric motor, or a hydraulic or pneumatic system.
Patent AT-E181464-T1 (AT)
Inventor: TENNIE HEINRICH
IPC: H01R43/26
Filed: 1995-08-31
Granted: 1999-07-15
Abstract: An electrical device is prepared with pre-mounted components with non-threaded wire insertion connection points. A first connection point is positioned in the wire application device's (25) operating region. A stripped wire (12) end is automatically mechanically applied to a contact zone for the first contact point. A second contact point is positioned at the operating region whilst the application device pays out a suitable length of conductor to avoid cable stress between the contact points. the wire is separated at a stripped region (18) to form an uninsulated insertion end for this contact point and a further insertion end for the next contact point. The first end is mechanically fixed in place and the process repeated until all desired connections are made to the component connection points.
Patent AT-E187821-T1 (AT)
Inventor: MATSUDA TAKEHISA MINOO HIGASHI
IPC: G02C7/04
Filed: 1995-03-14
Granted: 2000-01-15
Abstract: PCT No. PCT/JP95/00419 Sec. 371 Date Mar. 1, 1996 Sec. 102(e) Date Mar. 1, 1996 PCT Filed Mar. 14, 1995 PCT Pub. No. WO95/25287 PCT Pub. Date Sep. 21, 1995The present invention provides semi-spherical materials to be worn on the eyeball, such as contact lenses for visual acuity correction or medical treatment use, cornea protecting materials, controlled drug release contact lenses and the like, which comprise, as a main component, a glycosaminoglycan existing in the living body as an extracellular matrix component of connective tissues and satisfy various requirements such as dimentional stability, transparency, surface water wettability, tissue compatibility, oxygen permeability and the like. In other words, the material to be worn on the eyeball has a shape of semi-spherical surface compatible in shape with the mammalian eyeball and has biological and surface-physical compatibilities with ophthalmic tissues and comprises, as a main component, a substantially transparent photocured crosslinked-glycosaminoglycan obtained by allowing photoreactive groups covalently bonded to a glycosaminoglycan to crosslink mutually by photoirradiation.
Patent AT-E182309-T1 (AT)
Inventor: BAKX MARTINUS C M
IPC: B65D71/28
Filed: 1995-03-22
Granted: 1999-08-15
Abstract: An article carrier (10) for holding together a plurality of articles such as bottles (B1, B2). The carrier comprises opposed upper and lower walls (18, 22, 24) interconnected by spaced side walls (16, 20). Each of the upper and lower walls has a plurality of article receiving apertures (A). The apertures in the lower wall are in register with the apertures in the upper wall. The carrier has a billboard panel (14) depending from one of the side walls (16) and an internal partition structure(s) interconnecting the upper and lower walls. The partition structure is formed from material interposed between tow adjacent wall-forming portions (22, 24) of said lower wall. The partition structure comprises a pair of mutually hinged panel elements (S1, S3) disposed in face to face contacting relationship to provide an upstanding part of the partition structure when the carrier is in a set-up condition.
Patent AT-E202324-T1 (AT)
Inventor: ASTROEM PETER
IPC: B66C13/06
Filed: 1995-04-07
Granted: 2001-07-15
Abstract: The present invention relates to a device for damping undesirable oscillations of a crane member (1) which is pivotally movable by means of at least one hydraulic motor (5, 5'). The hydraulic circuit (8) has a restriction (13) co-operating with a circuit-closing device (14; 18) the purpose of the restriction being to convert energy inherent in the system to heat in the hydraulic oil. The device includes means (14, 15, 16, 16') for controlling the closing device (14; 18) according to instantaneous conditions and/or changes or conditions, such as pressure and/or flow, in the hydraulic circuit (8). The energy-converting action of the restriction (13) is instantaneously activated as soon as a certain condition and/or a certain change of condition occurs. The conduit (12) in which the restriction (13) lies is completely shut off, rendering flow of oil through the restriction impossible, as long as the energy-converting action of the restriction is not called for.
Patent AT-E231926-T1 (AT)
Inventor: NAKAMURA T NISSHIN
IPC: F16J15/06
Filed: 1995-06-07
Granted: 2003-02-15
Abstract: Elastic rotation rolls can be installed easily at optimal positions, and stable sealing performance can be attained for an extended period of time. Seal discs 47 are disposed at both ends of the roll shaft 46 of each elastic rotation roll 44 in the axial direction thereof. The outer peripheral surface of the seal disc 47 is closely contacted with the arc-shaped contact surface 52 of a sealing side wall 49 to attain sealing performance at each end face of the roll. Even if the seal disc 47 is displaced with respect to the sealing side wall 49, the sealing performance can be maintained. In this way, the structure of the sealing apparatus can be simplified and the elastic rotation rolls can be installed easily. <IMAGE>
Patent AT-E297045-T1 (AT)
Inventor: THORNER CRAIG
IPC: H04R1/00
Filed: 1995-09-20
Granted: 2005-06-15
Abstract: A control system that is responsive to an audio signal generated by an audio source such as a computer, video game console, stereo system and the like. The control system converts the audio signal into a control signal for a tactile sensation generator such as a vibrating cushion, vibrating seat pad, and the like. The control system contains an audio signal processor and a control signal generator. The audio signal processor produces a processed signal indicative of the amplitude, frequency, and rate of change of the audio signal. From the processed signal, a control signal generator produces a control signal for a tactile sensation generator. The control signal causes the tactile sensation generator to produce a tactile sensation corresponding to the present scene being displayed, for example, on a monitor of a computer executing a computer game.
Patent AT-E311815-T1 (AT)
Inventor: SCHUTT ERNEST G
IPC: A61K9/00
Filed: 1995-09-26
Granted: 2005-12-15
Abstract: A method for ultrasonic harmonic imaging is disclosed, which uses microbubbles particularly selected for their properties of reradiating ultrasound energy at frequencies other than the exciting frequency.
Patent AT-E189208-T1 (AT)
Inventor: ISAK HEINZ
IPC: C07B61/00
Filed: 1995-11-14
Granted: 2000-02-15
Abstract: PCT No. PCT/EP95/04463 Sec. 371 Date May 6, 1997 Sec. 102(e) Date May 6, 1997 PCT Filed Nov. 14, 1995 PCT Pub. No. WO96/16023 PCT Pub. Date May 30, 1996Halomethylbenzoyl cyanides I PH-CO-CN (I) where Ph is phenyl which is substituted by chloromethyl or bromomethyl and may cary 1-4 other rradicals, are prepared from halomethylbenzoyl chlorides II PH-CO-Cl (II), by reacting II with a cyanide-donating compound in the presence of a Lewis acid, if required in an inert organic solvent or diluent, and then isolating the product. The halomethylbenzoyl cyanides I are important intermediates for synthesizing crop protection agents.
Patent AT-E217644-T1 (AT)
Inventor: HEIDINGSFELD HERBERT
IPC: C08L55/02
Filed: 1996-04-11
Granted: 2002-06-15
Abstract: A process is claimed for the continuous prodn. of thermoplastic polyurethane (TPU)-copolymer mixts. from: (I) 1-60 wt% thermoplastic copolymer; and (II) 99-40 wt% of the polyurethane-forming components (A) di-isocyanate, (B) linear OH-terminated polyol with a mol. wt. of 500-5000 and (C) diol or diamine chain extenders with mol. wts. of 60-500. The process comprises: (i) feeding component (I) together with part of components (A), (B) and/or (C) into an extruder through a first inlet and feeding in the rest of components (A), (B) and/or (C) at one or more later inlets; (ii) reacting (A), (B) and (C), at a mole ratio of (NCO gps. in A):(NCO-reactive gps. in B and C) = 0.9-1.2, to form the TPU; and (iii) extruding the mixt. of TPU and (I).
Patent AT-E210138-T1 (AT)
Inventor: SIRGES WOLFRAM DR
IPC: B01J31/16
Filed: 1996-09-10
Granted: 2001-12-15
Abstract: (Bis-4,4'-dibenzofuran-3,3'-yl) bis-dihydrocarbyl phosphonates of formula (I) in the form of racemates or enantiomers are new. R<1> = 1-6C alkyl, aryl or aralkyl; or two R<1> gps. = 1-6C bridging hydrocarbon. Also claimed are (dibenzofuran-3-yl)dihydrocarbylphosphonates (II) of formula (A; X = P(=O)(OR<1>)2; Y = H) and (di-2-halo-benzofuran-3-yl)dihydrocarbyl phosphonates (III) of formula (A; X = P(=O)(OR<1>)2; Y = halogen).